Thibault Agripnidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thibault Agripnidis has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
Basile Kerleroux
6 shared publications- Gregoire Boulouis
Diagnostic and Interventional Neuroradiology, Tours University Hospital, and Imaging Brain & Neuropsychiatry iBraiN, INSERM U1253, France (G.B.).
5 shared publications - Jean-François Hak
Department of Neuroradiology, APHM La Timone, Marseille, France
4 shared publications - Benoit Testud
Aix-Marseille Univ, CNRS, CRMBM, UMR 7339, Marseille, France
3 shared publications - Gaultier Marnat
Department of Neuroradiology, Bordeaux University Hospital, Bordeaux, France
3 shared publications - Géraud Forestier
Department of Neuroradiology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
3 shared publications
Latest Publications
- 24 November 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (10)
Exclusion of Arteriovenous Shunts in Intracerebral Hemorrhage Using MRI Arterial Spin Labeling
- 24 November 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (10)
Exclusion of Arteriovenous Shunts in Intracerebral Hemorrhage Using MRI Arterial Spin Labeling
- 8 September 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (5)
Teaching NeuroImage: Utility of Arterial Spin Labeling in Detecting Occult Micro-AVM in Angiogram-Negative Acute ICH
- 8 September 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (5)
Teaching NeuroImage: Utility of Arterial Spin Labeling in Detecting Occult Micro-AVM in Angiogram-Negative Acute ICH
- 28 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (2) , e218338
Teaching NeuroImages: Clinical Utility of 7T MRI in the Management of a Basilar Artery Perforator Aneurysm
- 28 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (2) , e218338
Teaching NeuroImages: Clinical Utility of 7T MRI in the Management of a Basilar Artery Perforator Aneurysm
- 14 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (1) , e218251
Teaching NeuroImage: Utility of Arterial Spinal Labeling in Detecting Occult Micro-AVM in Angiogram-Negative Acute ICH
- 14 July 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (1) , e218251
Teaching NeuroImage: Utility of Arterial Spinal Labeling in Detecting Occult Micro-AVM in Angiogram-Negative Acute ICH
- Open Access
- 24 June 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (5) , 101580
Arterial spin labeling (ASL) MRI for detection and prognostication of residual perfusion in adult brain AVMs after gamma knife radiosurgery: A multicenter study
- 24 June 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (5) , 101580
Open AccessArterial spin labeling (ASL) MRI for detection and prognostication of residual perfusion in adult brain AVMs after gamma knife radiosurgery: A multicenter study
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (9) , e214874
Teaching NeuroImages: Clinical Utility of 7T MRI in the Management of a Basilar Artery Perforator Aneurysm
- 12 May 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (9) , e214874
Teaching NeuroImages: Clinical Utility of 7T MRI in the Management of a Basilar Artery Perforator Aneurysm
- Open Access
- 29 January 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (2) , 64
A New Generation of Eco-Designed Embolic Agents: Towards Sustainable and Personalized Interventional Radiology
Background: Embolization is a key therapeutic option in interventional radiology for the management of acute arterial bleeding and solid organ injuries. While various embolic agents exist, there is a persistent clinical need for materials that are not only highly effective but also biocompatible, easy to deliver, and cost-effective. We aim to evaluate a new eco-friendly dry foam agar-based embolization agent (ABEA) in an uncontrolled solid organ hemorrhage model. Material and Methods: Ten pigs underwent a controlled splenic injury. After a 5 min free-bleeding period, five pigs were treated with splenic artery ABEA embolization, while the remaining five received no treatment and served as the control group. Follow-up angiography was performed immediately after embolization and at 5 and 15 min in the treated pigs. Mean arterial pressures and average blood loss volumes were evaluated for 120 min. Results: The control group showed continuous blood loss, leading to a significantly higher total blood loss than the ABEA-treated group (1451 mL vs. 611 mL at 120 min, p < 0.05). Mean arterial pressure (MAP) remained below the hemorrhagic shock threshold throughout the procedure in the control group, validating the model of uncontrolled hemorrhage. In addition, a significant stabilization of MAP was observed in treated pigs, remaining above the critical level of hemorrhagic shock and differed significantly from control group values. Conclusions: Embolization with ABEA maintained MAP above critical levels and significantly reduced blood loss volume in a hemorrhagic model. These results support the technical feasibility and short-term hemostatic performance of ABEA in an acute setting. While preliminary, this proof-of-concept has provided the basis for a validated clinical study currently underway to evaluate its effectiveness and safety in human patients.
- 29 January 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (2) , 64
Open AccessA New Generation of Eco-Designed Embolic Agents: Towards Sustainable and Personalized Interventional Radiology
Background: Embolization is a key therapeutic option in interventional radiology for the management of acute arterial bleeding and solid organ injuries. While various embolic agents exist, there is a persistent clinical need for materials that are not only highly effective but also biocompatible, easy to deliver, and cost-effective. We aim to evaluate a new eco-friendly dry foam agar-based embolization agent (ABEA) in an uncontrolled solid organ hemorrhage model. Material and Methods: Ten pigs underwent a controlled splenic injury. After a 5 min free-bleeding period, five pigs were treated with splenic artery ABEA embolization, while the remaining five received no treatment and served as the control group. Follow-up angiography was performed immediately after embolization and at 5 and 15 min in the treated pigs. Mean arterial pressures and average blood loss volumes were evaluated for 120 min. Results: The control group showed continuous blood loss, leading to a significantly higher total blood loss than the ABEA-treated group (1451 mL vs. 611 mL at 120 min, p < 0.05). Mean arterial pressure (MAP) remained below the hemorrhagic shock threshold throughout the procedure in the control group, validating the model of uncontrolled hemorrhage. In addition, a significant stabilization of MAP was observed in treated pigs, remaining above the critical level of hemorrhagic shock and differed significantly from control group values. Conclusions: Embolization with ABEA maintained MAP above critical levels and significantly reduced blood loss volume in a hemorrhagic model. These results support the technical feasibility and short-term hemostatic performance of ABEA in an acute setting. While preliminary, this proof-of-concept has provided the basis for a validated clinical study currently underway to evaluate its effectiveness and safety in human patients.
- Open Access
- 2 January 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (1) , 101408
Tantalum sedimentation in Onyx® syringes: An in-vitro study of agitation strategies to maintain fluoroscopic visibility
- 2 January 2026
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 53 (1) , 101408
Open AccessTantalum sedimentation in Onyx® syringes: An in-vitro study of agitation strategies to maintain fluoroscopic visibility
- 14 May 2025
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (4) , 101350
Interventional neuroradiology in France in 2025: Scaling up expertise, access, and innovation
- 14 May 2025
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (4) , 101350
Interventional neuroradiology in France in 2025: Scaling up expertise, access, and innovation
- 29 April 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 914-922
Coincident intracranial aneurysm on the target vessel of acute ischemic stroke treated with mechanical thrombectomy: a multicentric case-control study
Background The presence of a coincident intracranial aneurysm (CIA) on the target vessel of patients undergoing mechanical thrombectomy (MT) for acute ischemic stroke (AIS) poses challenges, as the benefits and risks of the procedure in this scenario remain unclear. This study aimed to evaluate the efficacy and safety of MT in AIS cases with a CIA on the target vessel. Methods We retrospectively analyzed data from 14 stroke centers in France and Switzerland between January 2015 and January 2023. We identified AIS cases with CIA on the target vessel treated with MT. The control population was constituted from the ETIS registry (Endovascular Treatment in Ischemic Stroke), including AIS patients treated with MT in the same centers during the same period, and were matched (1:4) on age (±1 year) and sex. The primary outcome was favorable functional status at 3 months, defined as a modified Rankin Scale (mRS) score ≤2 or equal to pre-stroke mRS. Results A total of 104 MT-treated patients with at least one CIA on the target vessel and 416 MT-treated patients without CIA were analyzed. Despite an aneurysm rupture occurring in 5.8% of cases, no significant differences were observed in favorable functional outcome at 3 months between the CIA and control groups (42.4% vs 41.0%; adjusted OR 1.20, 95% CI 0.72 to 1.97). Similarly, recanalization rates (modified Thrombolysis In Cerebral Infarction (mTICI) ≥2b at end of MT) did not differ significantly (90.0% vs 85.9%; adjusted OR 1.75, 95% CI 0.77 to 3.95). Conclusion MT is an effective option for AIS patients, even with CIA on the target vessel, but the risk of rupture underscores the need for procedural planning. Future studies should further explore size and location criteria to optimize patient selection and orientation.
- 29 April 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 914-922
Coincident intracranial aneurysm on the target vessel of acute ischemic stroke treated with mechanical thrombectomy: a multicentric case-control study
Background The presence of a coincident intracranial aneurysm (CIA) on the target vessel of patients undergoing mechanical thrombectomy (MT) for acute ischemic stroke (AIS) poses challenges, as the benefits and risks of the procedure in this scenario remain unclear. This study aimed to evaluate the efficacy and safety of MT in AIS cases with a CIA on the target vessel. Methods We retrospectively analyzed data from 14 stroke centers in France and Switzerland between January 2015 and January 2023. We identified AIS cases with CIA on the target vessel treated with MT. The control population was constituted from the ETIS registry (Endovascular Treatment in Ischemic Stroke), including AIS patients treated with MT in the same centers during the same period, and were matched (1:4) on age (±1 year) and sex. The primary outcome was favorable functional status at 3 months, defined as a modified Rankin Scale (mRS) score ≤2 or equal to pre-stroke mRS. Results A total of 104 MT-treated patients with at least one CIA on the target vessel and 416 MT-treated patients without CIA were analyzed. Despite an aneurysm rupture occurring in 5.8% of cases, no significant differences were observed in favorable functional outcome at 3 months between the CIA and control groups (42.4% vs 41.0%; adjusted OR 1.20, 95% CI 0.72 to 1.97). Similarly, recanalization rates (modified Thrombolysis In Cerebral Infarction (mTICI) ≥2b at end of MT) did not differ significantly (90.0% vs 85.9%; adjusted OR 1.75, 95% CI 0.77 to 3.95). Conclusion MT is an effective option for AIS patients, even with CIA on the target vessel, but the risk of rupture underscores the need for procedural planning. Future studies should further explore size and location criteria to optimize patient selection and orientation.